Health legislation moving through Congress would force drug makers to disclose how much they spend on continuing medical education classes for doctors has sparked some resistance from the industry, the Wall Street Journal
reports. Defenders of industry funding say the money helps pay for high-quality classes that keep doctors up to date on the latest treatments. They say the classes are developed independent of industry influence. The healthcare overhaul bill that passed the full House mandates disclosure of drug and medical-device industry payments to both doctors and third parties, including medical-education companies. Senate versions of the bill don't require the disclosure of third-party payments.